{"id":"morte-mescaline","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Insomnia"}]},"_chembl":{"chemblId":"CHEMBL26687","moleculeType":"Small molecule","molecularWeight":"211.26"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting the reuptake of these neurotransmitters, morte-mescaline increases their concentrations in the synaptic cleft, leading to enhanced neurotransmission and associated psychoactive effects.","oneSentence":"Morte-mescaline is a potent serotonin, norepinephrine, and dopamine reuptake inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:53.354Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant depression"}]},"trialDetails":[{"nctId":"NCT05933213","phase":"PHASE4","title":"Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2023-07-06","conditions":"Lupus Nephritis","enrollment":205}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Morte-mescaline","genericName":"Morte-mescaline","companyName":"Xiangya Hospital of Central South University","companyId":"xiangya-hospital-of-central-south-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Morte-mescaline is a potent serotonin, norepinephrine, and dopamine reuptake inhibitor. Used for Treatment-resistant depression.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}